16th Biosimilar Conference

This year’s flagship event will gather top EU and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilar medicines sector in “Biosimilar Medicines: Unlocking the Full Potential of Biologics”.

Over two days, participants will dive into a dynamic programme – a crossroads between technical, scientific, market discussions and the overarching healthcare policy agenda.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
16th Biosimilar Conference
css.php